KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oracle (ORCL) Research & Development (2016 - 2026)

Oracle (ORCL) has disclosed Research & Development for 18 consecutive years, with $2.6 billion as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 7.33% year-over-year to $2.6 billion, compared with a TTM value of $10.3 billion through Feb 2026, up 9.33%, and an annual FY2025 reading of $9.9 billion, up 10.6% over the prior year.
  • Research & Development was $2.6 billion for Q1 2026 at Oracle, up from $2.6 billion in the prior quarter.
  • Across five years, Research & Development topped out at $2.7 billion in Q2 2025 and bottomed at $1.8 billion in Q1 2022.
  • Average Research & Development over 5 years is $2.3 billion, with a median of $2.2 billion recorded in 2023.
  • The sharpest move saw Research & Development rose 24.29% in 2022, then changed 0.0% in 2024.
  • Year by year, Research & Development stood at $2.2 billion in 2022, then rose by 3.15% to $2.2 billion in 2023, then grew by 11.01% to $2.5 billion in 2024, then rose by 3.6% to $2.6 billion in 2025, then rose by 1.84% to $2.6 billion in 2026.
  • Business Quant data shows Research & Development for ORCL at $2.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.5 billion in Q3 2025.